Top Markets
Coin of the day
BriaCell Therapeutics Corp. BriaCell Therapeutics Corp.

BriaCell Therapeutics Corp.

BCTX
Rangering i aksjer #18288
BriaCell Therapeutics Corp., an immuno-oncology biotechnology company, engages... BriaCell Therapeutics Corp., an immuno-oncology biotechnology company, engages in developing immunotherapies for the treatment of cancer. Its lead candidate is Bria-IMT that is in Phase I/IIa clinical trial in a combination study with immune checkpoint inhibitors for the treatment of breast cancer. The company also has a cooperative research and development agreement with the National Cancer Institute for developing Bria-OTS, a personalized immunotherapy for advanced breast cancer; and BriaDx, a diagnostic test. BriaCell Therapeutics Corp. is headquartered in West Vancouver, Canada.
Aksjekurs
$4.32
Markedsverdi
$8.14M
Endring (1 dag)
-6.49%
Endring (1 år)
-2.88%
Land
CA
Handel BriaCell Therapeutics Corp. (BCTX)

Kategori

P/B-forhold for BriaCell Therapeutics Corp. (BCTX)
P/B-forhold per 2026 TTM: 0
Ifølge BriaCell Therapeutics Corp. sine siste finansielle rapporter og aksjekurs er selskapets nåværende P/B-forhold (TTM) 0. Ved slutten av 2026 hadde selskapet et P/B-forhold på 0.
P/B-historikk for BriaCell Therapeutics Corp. fra 2026 til 2026
P/B-forhold ved hvert års slutt
År P/B-forhold Endre
Ikke nok data for de angitte datoene.
P/B-forhold for lignende selskaper eller konkurrenter
Selskap P/B-forhold Forskjell i P/B-forhold Land
5.6367 -
DK
6.0433 -
US
2.4872 -
US
4.7311 -
BE
6.9706 -
NL